Outlook Therapeutics Presents Positive NORSE THREE Safety Data for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) at EURETINA Virtual 2021 Medical Conference

NEXT STORY
SCYNEXIS Announces Hansoh Pharma’s Application to National Medical Products Administration (NMPA) in China for Phase 3 Trial of Ibrexafungerp for Treatment of Vulvovaginal Candidiasis (VVC)
PREV STORY
Acepodia to Present Data from Preclinical and Phase 1 Studies of ACE1702 at the European Society for Medical Oncology (ESMO) 2021 Virtual Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

One Medical Announces Plans to Enter North Carolina and Wisconsin

author_avatar
NASDAQ Market News

Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza

First and only single-dose oral medicine approved to treat the flu Xofluza significantly reduced ...

author_avatar
NASDAQ Market News

American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa

author_avatar
NASDAQ Market News